Literature DB >> 8670881

Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease.

T Okamoto1, S Takeda, U Giambarella, Y Murayama, T Matsui, T Katada, Y Matsuura, I Nishimoto.   

Abstract

APP695 is a transmembrane precursor of Abeta amyloid. In familial Alzheimer's disease (FAD), three mutations V642I/F/G were discovered in APP695, which has been suggested by multiple studies to be a cell surface signaling receptor. We previously reported that normal APP695 encodes a potential GO-linked receptor with ligand-regulated function and that expression of the three FAD mutants (FAD-APPs), not normal APP, induces cellular outputs by GO-dependent mechanisms. This suggests that FAD-APPs are constitutively active GO-linked receptors. Here, we provide direct evidence for this notion. Reconstitution of either recombinant FAD-APP with GO vesicles induced activation of GO, which was inhibitable by pertussis toxin, sensitive to Mg2+ and proportional in quantity to the reconstituted amounts of FAD-APP. Consistent with the dominant inheritance of this type of FAD, this function was dominant over normal APP, because little activation was observed in APP695-GO vesicles. Experiments with antibody competition and sequence deletion indicated that His657-Lys676 of FAD-APP, which has been specified as the ligand-dependent GO-coupling domain of normal APP, was responsible for this constitutive activation, confirming that the three FAD-APPs are mutationally activated APP695. This study identifies the intrinsic signaling function of APP to be a novel target of hereditary Alzheimer's disease mutations, providing an in vitro system for the screening of potential FAD inhibitors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670881      PMCID: PMC452057     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

1.  Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate.

Authors:  Y Murayama; T Okamoto; E Ogata; T Asano; T Iiri; T Katada; M Ui; J H Grubb; W S Sly; I Nishimoto
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

2.  beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity.

Authors:  H Zheng; M Jiang; M E Trumbauer; D J Sirinathsinghji; R Hopkins; D W Smith; R P Heavens; G R Dawson; S Boyce; M W Conner; K A Stevens; H H Slunt; S S Sisoda; H Y Chen; L H Van der Ploeg
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

3.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

4.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.

Authors:  E I Rogaev; R Sherrington; E A Rogaeva; G Levesque; M Ikeda; Y Liang; H Chi; C Lin; K Holman; T Tsuda
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

5.  Participation of the protein Go in multiple aspects of behavior in C. elegans.

Authors:  J E Mendel; H C Korswagen; K S Liu; Y M Hajdu-Cronin; M I Simon; R H Plasterk; P W Sternberg
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

6.  Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor.

Authors:  R A Bond; P Leff; T D Johnson; C A Milano; H A Rockman; T R McMinn; S Apparsundaram; M F Hyek; T P Kenakin; L F Allen
Journal:  Nature       Date:  1995-03-16       Impact factor: 49.962

7.  Modulation of serotonin-controlled behaviors by Go in Caenorhabditis elegans.

Authors:  L Ségalat; D A Elkes; J M Kaplan
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

8.  Direct control of exocytosis by receptor-mediated activation of the heterotrimeric GTPases Gi and G(o) or by the expression of their active G alpha subunits.

Authors:  J Lang; I Nishimoto; T Okamoto; R Regazzi; C Kiraly; U Weller; C B Wollheim
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

9.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

10.  Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro.

Authors:  B Allinquant; P Hantraye; P Mailleux; K Moya; C Bouillot; A Prochiantz
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  16 in total

Review 1.  Molecular mechanisms of go signaling.

Authors:  Meisheng Jiang; Neil S Bajpayee
Journal:  Neurosignals       Date:  2009-02-12

Review 2.  Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences.

Authors:  Philip F Copenhaver; Donat Kögel
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

3.  c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK.

Authors:  S Matsuda; T Yasukawa; Y Homma; Y Ito; T Niikura; T Hiraki; S Hirai; S Ohno; Y Kita; M Kawasumi; K Kouyama; T Yamamoto; J M Kyriakis; I Nishimoto
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

4.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 5.  Neuronal migration during development and the amyloid precursor protein.

Authors:  Philip F Copenhaver; Jenna M Ramaker
Journal:  Curr Opin Insect Sci       Date:  2016-08-16       Impact factor: 5.186

6.  Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases.

Authors:  Y Hashimoto; H Jiang; T Niikura; Y Ito; A Hagiwara; K Umezawa; Y Abe; Y Murayama; I Nishimoto
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 7.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

8.  Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin.

Authors:  Takako Niikura; Hirohisa Tajima; Yoshiko Kita
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

9.  AP-2 participates in the transcriptional control of the amyloid precursor protein (APP) gene in oral squamous cell carcinoma.

Authors:  Matthew J Provenzano; Lei Yu; Michael J Hitchler; Matthew P Fitzgerald; Robert A Robinson; Sigrid Wayne; Mark Ver Meer; Frederick E Domann
Journal:  Exp Mol Pathol       Date:  2007-06-26       Impact factor: 3.362

10.  Amyloid precursor proteins interact with the heterotrimeric G protein Go in the control of neuronal migration.

Authors:  Jenna M Ramaker; Tracy L Swanson; Philip F Copenhaver
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.